Baker McKenzie advised Sofinnova Partners and Asabys Partners on the deal. Sofinnova Partners and Asabys Partners led a 12 million euros investment round in Barcelona-based biotech...
Nuage Therapeutics’ 12€ Million Investment Round
Moon Surgical’s EUR55.4 Million Fundraising
Bird & Bird advised Moon Surgical on its new round. GT Healthcare Capital & Partners, Cathay Health and Johnson & Johnson Innovation were advised by Goodwin....
Amolyt Pharma’s EUR 138 Million Fund Raising
Goodwin advised Sofinnova Partners, Intermediate Capital Group, Tekla et CTI Life Sciences. Jones Day advised Amolyt Pharma. McDermott Will & Emery advised Andera Partners, Novo Holdings...
Apollo Global Management’s Partnership With Sofinnova Partners
Paul, Weiss, Rifkind, Wharton & Garrison and Gide advised Apollo Global Management, while Dechert advised Sofinnova Partners in the deal. Apollo Global Management announced its strategic...
Elicit Plant’s €16 Million Series A Financing Round
Goodwin Procter advised Sofinnova Partners, Bpifrance and ECBF on the deal. Ydès advised Elicit Plant. Sofinnova Partners, Bpifrance and ECBF led the €16 million Series A financing...
GlycoEra’s CHF 45 Million Series A Financing Round
Vischer advised GlycoEra AG on the deal. Walder Wyss advised 5AM Ventures, Roche Venture Fund and Sofinnova Partners as lead investors. GlycoEra AG has closed CHF...
Mnemo Therapeutics’ €75 Million Series A Financing Round
IN BRIEF: Gide Loyrette Nouel, Goodwin Procter, advised on the matter. Gide Loyrette Nouel advised Mnemo Therapeutics with a team including David-James Sebag (Picture – Corporate...